Drugmaker Abbott Laboratories agreed to pay $22.5 million to settle allegations it tried to block generic competition to a popular cholesterol medication, according to state officials.
chicagotribune.com - Business, Chicago Tribune: Business
Thu, 01/07/2010 - 11:00pm
Drugmaker Abbott Laboratories agreed to pay $22.5 million to settle allegations it tried to block generic competition to a popular cholesterol medication, according to state officials.